The Food and Drug Administration approved the first skin patch treatment for attention deficit hyperactivity disorder, giving the go-ahead Thursday for Daytrana from Noven Pharmaceuticals (NOVN:Nasdaq - commentary - research - Cramer's Take) and Shire (SHPGY:Nasdaq ADR - commentary - research - Cramer's Take).
Is it just me or does expecting kids with ADHD to not peel it off within 5 minutes seem a little optimistic? |